Are there any contraindications for a 17-year-old patient with a history of seizures and ganglioglioma to receive Measles, Mumps, and Rubella (MMR) vaccine, Varicella (chickenpox) vaccine, Meningococcal (meningitis) vaccine, and Tetanus, Diphtheria, and Pertussis (TDAP) vaccine on the same day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaccination Recommendations for a 17-Year-Old with Ganglioglioma and History of Seizures

There are no absolute contraindications for a 17-year-old patient with ganglioglioma and history of seizures to receive MMR, varicella, meningococcal, and Tdap vaccines on the same day, but separate MMR and varicella vaccines are preferred over the combination MMRV vaccine due to the patient's seizure history.

Assessment of Individual Vaccines

MMR and Varicella Vaccines

  • For patients with a history of seizures, separate MMR and varicella vaccines are preferred over the combination MMRV vaccine 1
  • A personal history of seizures is considered a precaution (not a contraindication) for MMRV vaccine use 1
  • Children with a personal history of seizures should generally receive MMR and varicella vaccines separately rather than the combination MMRV vaccine 1, 2
  • The risk of febrile seizures after MMR vaccination is primarily in children aged 12-23 months (8-14 days post-vaccination), which is not applicable to this 17-year-old patient 3

Tdap Vaccine

  • The acellular pertussis vaccine (in Tdap) has a lower risk of inducing fever compared to whole-cell pertussis vaccines 1
  • For patients with a history of seizures, acellular pertussis vaccine (Tdap) is the vaccine of choice 1
  • Patients with stable neurologic conditions, including well-controlled seizures, may be safely vaccinated with Tdap 1

Meningococcal Vaccine

  • There are no specific contraindications for meningococcal vaccination in patients with seizure disorders or brain tumors
  • Meningococcal vaccines are inactivated vaccines that can be administered simultaneously with other vaccines 2

Simultaneous Administration Considerations

  1. Safety of Multiple Vaccines:

    • Advisory Committee on Immunization Practices (ACIP) supports simultaneous administration of all indicated vaccines 1, 2
    • Multiple vaccines can be safely administered during the same visit at different anatomical sites 2
  2. Special Precautions for Seizure History:

    • Consider prophylactic antipyretics: Acetaminophen or ibuprofen may be administered at the time of vaccination and every 4 hours for 24 hours afterward to reduce the possibility of post-vaccination fever 1
    • Ensure the patient's seizure condition is stable and well-controlled before vaccination 1
  3. Administration Guidelines:

    • Each vaccine must be administered at a different injection site using separate syringes 2
    • Clearly document each vaccine administered, including manufacturer, lot number, site, and date of administration 2

Risk Assessment

  1. Febrile Seizure Risk:

    • The risk of febrile seizures after MMR vaccination primarily affects children aged 12-23 months, not adolescents 4, 3
    • The risk of febrile seizures after DTaP-containing vaccines is primarily on the day of vaccination and in young children, not adolescents 5
  2. Ganglioglioma Considerations:

    • There are no specific contraindications for vaccination in patients with brain tumors like ganglioglioma
    • The priority is ensuring the patient's neurologic condition is stable before vaccination 1

Practical Recommendations

  1. Pre-vaccination Assessment:

    • Confirm the patient's seizures are well-controlled
    • Review current medications for potential interactions
  2. Vaccination Plan:

    • Administer MMR and varicella as separate injections (not as MMRV)
    • Administer Tdap and meningococcal vaccines at different injection sites
    • Consider prophylactic antipyretics (acetaminophen or ibuprofen) at the time of vaccination and for 24 hours afterward
  3. Post-vaccination Monitoring:

    • Monitor for fever development within 24 hours after vaccination
    • Advise caregivers about possible mild side effects and when to seek medical attention

Important Caveats

  • If the patient's neurologic condition is not stable or seizures are not well-controlled, consider delaying vaccination until the condition stabilizes 1
  • If the patient is on immunosuppressive therapy for ganglioglioma treatment, additional evaluation may be needed regarding the timing of live vaccines (MMR and varicella)
  • Document any previous adverse reactions to vaccines

By following these guidelines, the 17-year-old patient with ganglioglioma and history of seizures can safely receive the recommended vaccines on the same day with appropriate precautions to minimize the risk of adverse events.

Related Questions

What is the best approach to manage a 30-year-old patient in the Emergency Department (ED) with a rash, who is vaccinated against chickenpox and received a Measles, Mumps, and Rubella (MMR) vaccine 2 weeks ago, and reports having protected sex?
What vaccines should be given today to a 3-year-old child due for influenza (flu), Diphtheria, Tetanus, and Pertussis (DTaP), polio, pneumococcal, Haemophilus influenzae type b (Hib), Hepatitis A (Hep A), varicella, and Measles, Mumps, and Rubella (MMR) vaccines?
What is the best recommendation for a 27-year-old primigravid (first pregnancy) woman at 16 weeks gestation, with a blood type of O, Rh negative, and no immunity to Rubella (German measles) and Varicella (chickenpox), presenting with mild anemia (hemoglobin 11.2 g/dL) and normocytic anemia (mean corpuscular volume 84 fL)?
Are there new Measles (Rubeola) vaccine recommendations?
What vaccinations are recommended at 1 year of age?
What is the difference between central and proximal splenorenal (spleen to renal vein) shunts?
Can I prescribe vitamin D (Cholecalciferol) 50,000 units to a patient on a GLP-1 (Glucagon-like peptide-1) receptor agonist?
What are the management options for back pain 3 months post cesarean section (C-section)?
What is the initial workup for a patient presenting with dark urine?
What is the initial workup and management for a patient presenting with a scrotal mass diagnosed as a varicocele (varicose vein in the scrotum)?
What is the initial workup for a patient presenting with a painless scrotal mass?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.